RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Precision BioSciences Stock

Precision BioSciences Net Income 2024

Precision BioSciences Net Income

-460,912.5 USD

Ticker

DTIL

ISIN

US74019P1084

WKN

A2PGA1

In 2024, Precision BioSciences's profit amounted to -460,912.5 USD, a -99.25% increase from the -61.32 M USD profit recorded in the previous year.

The Precision BioSciences Net Income history

YEARNET INCOME (undefined USD)
2030e14.01
2029e12.76
2028e6.34
2027e3.91
2026e-37.6
2025e-49.06
2024e-0.46
2023-61.32
2022-111.64
2021-30.6
2020-109.01
2019-92.88
2018-46.04
2017-21.1
2016-8.25

Precision BioSciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Precision BioSciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Precision BioSciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Precision BioSciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Precision BioSciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Precision BioSciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Precision BioSciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Precision BioSciences’s growth potential.

Precision BioSciences Revenue, EBIT and net profit per share

DatePrecision BioSciences RevenuePrecision BioSciences EBITPrecision BioSciences Net Income
2030e557.37 M USD330.45 M USD14.01 M USD
2029e44.52 M USD301.2 M USD12.76 M USD
2028e41 M USD-98.68 M USD6.34 M USD
2027e30.22 M USD-87.92 M USD3.91 M USD
2026e22.56 M USD-78.8 M USD-37.6 M USD
2025e20.28 M USD-74.64 M USD-49.06 M USD
2024e82.36 M USD-48.1 M USD-460,912.5 USD
202348.73 M USD-43.74 M USD-61.32 M USD
202225.1 M USD-62.31 M USD-111.64 M USD
2021115.53 M USD-39.38 M USD-30.6 M USD
202024.29 M USD-109.83 M USD-109.01 M USD
201922.24 M USD-87.2 M USD-92.88 M USD
201810.88 M USD-47.91 M USD-46.04 M USD
20176.48 M USD-21.86 M USD-21.1 M USD
20167.02 M USD-8.83 M USD-8.25 M USD

Precision BioSciences stock margins

The Precision BioSciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Precision BioSciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Precision BioSciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Precision BioSciences's sales revenue. A higher gross margin percentage indicates that the Precision BioSciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Precision BioSciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Precision BioSciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Precision BioSciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Precision BioSciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Precision BioSciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Precision BioSciences Margin History

Precision BioSciences Gross marginPrecision BioSciences Profit marginPrecision BioSciences EBIT marginPrecision BioSciences Profit margin
2030e0 %59.29 %2.51 %
2029e0 %676.57 %28.66 %
2028e0 %-240.66 %15.47 %
2027e0 %-290.95 %12.93 %
2026e0 %-349.34 %-166.67 %
2025e0 %-368.05 %-241.88 %
2024e0 %-58.4 %-0.56 %
20230 %-89.76 %-125.84 %
20220 %-248.26 %-444.8 %
20210 %-34.08 %-26.49 %
20200 %-452.25 %-448.86 %
20190 %-392.14 %-417.65 %
20180 %-440.25 %-423.02 %
20170 %-337.08 %-325.45 %
20160 %-125.84 %-117.62 %

Precision BioSciences Aktienanalyse

What does Precision BioSciences do?

Precision BioSciences was founded in 2006 in Durham, North Carolina, USA and is a biotech company specializing in the development of genome editing technologies. The company's main products are genomic single-strand cutter (GSSC) enzymes and related solutions that provide advanced ways to edit genomes. Precision BioSciences focuses on creating innovative technologies and partnerships with industrial, scientific, and academic partners. Through the development of new products and expanding its business relationships, Precision BioSciences has built a strong market presence in recent years. Precision BioSciences has two business divisions: Genome Editing and Food. The Genome Editing division is dedicated to developing new technologies for modifying genes in living cells. A key product of this division is ARCUS, a patented gene editing toolkit. ARCUS consists of two main components, a GSSC enzyme and a specific DNA target, and provides detailed, precise, and controlled editing of genomes. The technology offers a high level of flexibility, efficiency, and precision. The Food division focuses on the development of plants in agriculture and serves as an important complement to the Genome Editing division. Precision BioSciences uses advanced technologies like ARCUS to edit the genomics of plants and improve their traits, such as resistance to pests or heat. The company works closely with scientific partners and the agricultural industry to develop innovative solutions for the requirements of modern farming. Precision BioSciences has introduced a range of impressive products that meet the growing demand for genome editing. Some notable products include: CAR T-cell therapy: A revolutionary cancer treatment that uses inactivated virus and ARCUS technology to achieve outstanding results in the treatment of leukemias and lymphomas. Advanced papaya: This technology utilizes ARCUS to produce papayas that have resistance to papaya virus disease. This innovative solution aims to increase crop yields and reduce crop loss. PrecisionXtract: A new service that processes patient data to ensure precise and effective genome editing. This product is designed to meet the requirements of clinical studies and medical procedures while ensuring safety and sustainability. Overall, Precision BioSciences has established its position in the genome editing market thanks to its innovative product line, strong partnerships, and comprehensive knowledge and expertise. With a solid footing in the genome editing market, Precision BioSciences is well-positioned to continue expanding and developing innovative solutions for the genomics of humans, animals, and plants. Precision BioSciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Precision BioSciences's Profit Margins

The profit margins of Precision BioSciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Precision BioSciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Precision BioSciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Precision BioSciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Precision BioSciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Precision BioSciences stock

How much profit has Precision BioSciences made this year?

Precision BioSciences has made -460,912.5 USD this year.

How has the profit developed compared to last year?

The profit has increased by -99.25% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Precision BioSciences publish its earnings?

Precision BioSciences publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Precision BioSciences?

The profits of Precision BioSciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Precision BioSciences?

You can learn more about the earnings of Precision BioSciences by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Precision BioSciences pay?

Over the past 12 months, Precision BioSciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Precision BioSciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Precision BioSciences?

The current dividend yield of Precision BioSciences is .

When does Precision BioSciences pay dividends?

Precision BioSciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Precision BioSciences?

Precision BioSciences paid dividends every year for the past 0 years.

What is the dividend of Precision BioSciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Precision BioSciences located?

Precision BioSciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Precision BioSciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Precision BioSciences from 9/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did Precision BioSciences pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of Precision BioSciences in the year 2023?

In the year 2023, Precision BioSciences distributed 0 USD as dividends.

In which currency does Precision BioSciences pay out the dividend?

The dividends of Precision BioSciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Precision BioSciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Precision BioSciences

Our stock analysis for Precision BioSciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Precision BioSciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.